Global Heatstroke Treatment Market – Industry Trends and Forecast to 2030

Global Heatstroke Treatment Market, By Types (Exertional Heat Stroke, Non-Exertional Heat Stroke), Mechanism of Action (Antihistamines, Diuretics, Sedatives, Stimulants, Anticonvulsants, Vasoconstrictors, Others), Drugs (Dantrolene, Midazolam, Clonidine, Meperidine, Others), Diagnosis (Rectal Temperature, Blood Test, Urine Test, Muscle Function Test, Others), Treatment (Medication, Cold Therapy, Supportive Care), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End Users (Hospitals, Homecare, Specialty Clinics,  Others) – Industry Trends and Forecast to 2030.

Heatstroke Treatment Market Analysis and Size

Heatstroke is a life-threatening medical emergency caused by prolonged exposure to high temperatures, resulting in a dangerous elevation of the body's core temperature. Symptoms include confusion, rapid pulse, nausea, and unconsciousness. Immediate cooling and medical attention are crucial. Growing prevalence of participants in military training around the globe is a major factor fostering the growth of the global heatstroke treatment market. Rising expenditure on the development of healthcare infrastructure and increased adoption of sports as a career are other factors also fostering the growth of the global heatstroke treatment market.

Data Bridge Market Research analyses that the global heatstroke treatment market which was USD 10,387.00 million in 2022, is expected to reach USD 13,332.57 million by 2030 and is expected to undergo a CAGR of 6.00% during the forecast period of 2023 to 2030. "Medication" dominates the treatment segment of the heatstroke treatment market owing to the growing demand for treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Heatstroke Treatment Market Scope and Segmentation

Market Definition

Heatstroke is the most serious kind of heat injury. Heatstroke is when the body has experienced prolonged exposure to high temperatures and suffered a stroke. Heatstroke occurs when the body temperature rises above 104 F or 40ºC. Heatstroke is a life-threatening medical emergency characterized by a dangerous elevation of the body's core temperature, due to prolonged exposure to high temperatures and inadequate heat dissipation mechanisms. Symptoms include confusion, rapid pulse, flushed skin, nausea, and even loss of consciousness. Heatstroke can result in organ damage, seizures, or death if not promptly treated. Immediate cooling measures, such as moving the person to a cooler environment, removing excess clothing, and applying cold compresses, are vital. Seeking immediate medical attention is crucial to prevent severe complications.

Global Heatstroke Treatment Market Dynamics

Drivers

• Increasing Global Temperature and Climate Change

Global temperature rise and climate change are the main drivers of the global heat treatment market. As the frequency and intensity of heat waves increase, so does the number of cases of heat stroke. This increases the demand for effective treatment options and accelerates research and development in the field.

• Growing Awareness about Heatstroke

Awareness of the risks and consequences of heatstroke is increasing among the population, health professionals, and policymakers. This increased awareness leads to early detection and diagnosis of heat stroke cases, increases the demand for treatment options, and drives market growth.

• Occupational Heat Exposure

Certain occupations, such as outdoor workers, firefighters, and athletes, are prone to heat stroke due to prolonged exposure to high temperatures. As occupational safety standards improve and regulations become more stringent, there is an increased emphasis on providing effective treatment options for heat illnesses, including heat stroke.

• Growing Investment in Healthcare Facilities

The surging focus on improving healthcare facilities conditions and overall healthcare infrastructure is another important factor fostering market growth. The rising number of partnerships and strategic collaborations between the public and private players about funding and application of new and improved technology further creates lucrative market opportunities.

Opportunities

• Development of Novel Therapies

The global heatstroke market has an opportunity to focus on the development of new forms of treatment. Research and development can be used to investigate new pharmacological agents, therapeutic interventions, and treatments that improve the treatment of heat stroke. This includes research into potential neuroprotective drugs, anti-inflammatory agents, and innovative cooling techniques to improve patient outcomes and recovery.

• Expansion of Telemedicine and Remote Monitoring

Introducing telemedicine and remote monitoring technologies provides an opportunity for the heat treatment market. Remote monitoring devices can monitor vital signs, body temperature, and other related parameters, allowing healthcare professionals to provide real-time guidance and work remotely. This enables timely and accurate management of heatstroke cases, especially in remote or underserved areas where immediate access to medical facilities may be limited.

Restraints/Challenges

• Limited access to healthcare facilities

Access to appropriate healthcare facilities and medical professionals is critical for effective heat treatment. Certain areas, especially rural or underdeveloped areas, may lack access to health facilities equipped for heatstroke cases. The limited availability of emergency services, specialized cooling equipment, and trained healthcare providers can significantly limit the market when timely treatment becomes difficult.

• Variability in Heatstroke Presentation and Diagnosis

Heatstroke can cause varying symptoms and degrees of severity, making it difficult to diagnose and differentiate it from other heat-related illnesses accurately. The lack of specific diagnostic signs or standard diagnostic criteria challenges healthcare providers to identify cases of heatstroke and initiate appropriate treatment quickly.

This global heatstroke treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global heatstroke treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2019, FLIR Systems Inc. announced its expansion into the United States in Virginia by opening a new headquarters, strengthening the company's presence in Washington. This will help the company grow and create a new space to showcase the technology.

Global Heatstroke treatment Market Scope

The global heatstroke treatment market is segmented on the basis of types, mechanism of action, drugs, diagnosis, treatment, route of administration, distribution channel, and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Exertional Heat Stroke
• Non-Exertional Heat Stroke

Mechanism of Action

• Antihistamines
• Diuretics
• Sedatives
• Stimulants
• Anticonvulsants
• Vasoconstrictors
• Others

Drugs

• Dantrolene
• Midazolam
• Clonidine
• Meperidine
• Others

Diagnosis

• Rectal temperature
• Blood test
• Urine test
• Muscle function test
• Others

Treatment

• Medication
• Cold Therapy
• Supportive Care

Route of administration

• Oral
• Parenteral

Distribution channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

End Users

• Hospitals
• Homecare
• Specialty Clinics

Global Heatstroke Treatment Market Regional Analysis/Insights

The global heatstroke treatment market is analysed and market size insights and trends are provided by country, types, mechanism of action, drugs, diagnosis, treatment, route of administration, distribution channel, and end users as referenced above.

The countries covered in the global heatstroke treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America is expected to dominate the global heatstroke treatment market owing to the prevalence of advanced healthcare infrastructure and the rising prevalence of heatstroke.

Asia-Pacific is expected to grow with the highest CAGR in the global heatstroke treatment market for the forecast period of 2023 to 2030. This is because of the rising expenditure to develop healthcare infrastructure, the ever-rising geriatric population, and increasing personal disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global heatstroke treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global heatstroke treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global heatstroke treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Heatstroke treatment Market Share Analysis

The global heatstroke treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global heatstroke treatment market.

Some of the major players operating in the global heatstroke treatment market are:

• Novartis AG (Switzerland)
• AstraZeneca (U.K.)
• Pfizer Inc. (U.S.)
• Sanofi (France)
• Johnson & Johnson Services, Inc. (U.S.)
• AbbVie Inc. (U.S.)
• Allergan (Ireland)
• Merck & Co., Inc. (U.S.)
• Amgen Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Takeda Pharmaceutical Company Limited (Japan)
• Abbott (U.S.), Mankind Pharma (India)
• Eagle Pharmaceuticals, Inc. (U.S.)
• DAIICHI SANKYO COMPANY, LIMITED (Japan)
• Patanjali Ayurved. (India), Otsuka Holdings Co., Ltd. (Japan)
• Eli Lilly and Company (U.S.)
• Medisim (Israel)

SKU-46285